An analysis of the clinical efficacy and safety of a temperature-sensitive liquid embolic agent loaded with lobaplatin for the treatment of unresectable primary hepatocellular carcinoma through chemoembolization
The use of temperature-sensitive liquid embolic agents loaded with lobaplatin for chemoembolization in the treatment of unresectable primary liver cancer is a safe and effective therapeutic modality.
Authors
- Junsheng Zhong
- Jian Chen (ORCID: https://orcid.org/0000-0002-1694-7763)
- Qingfeng Lin (ORCID: https://orcid.org/0009-0008-3313-4124)
- Shengyu Zhou (ORCID: https://orcid.org/0000-0002-6254-2986)
Institutions
- Fujian Medical University (CN)
- Jiangxi Chest Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-05-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_2250_24
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64